Sun BioPharma, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 9/06/2017
Contact Info
  • 712 Vista Blvd
  • Suite 305
  • Waconia, MN 55387

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001029125
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 9 a/o Aug 31, 2017
Company Officers/Contacts
Michael T. Cullen Co-Founder
David B. Kaysen President, CEO
Tammy Groene VP, Ops.
Scott Kellen Vice President, CFO
Suzanne Gagnon CMO
Thomas X. Neenan CSO
Company Directors
Michael T. Cullen Executive Chairman
Suzanne Gagnon
Dr. Dalvir S. Gill Independent Director, Nominating Committee Member
J. Robert Paulson, Jr. Independent Director, Compensation Committee Member, Nominating Committee Member
David B. Kaysen
Jeffrey S. Mathiesen Independent Director, Audit Committee Member, Nominating Committee Member
Paul W. Schaffer Independent Director
D. Robert Schemel Independent Director, Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Cherry, Bekaert & Holland, L.L.P.
401 East Jackson St
Suite 3400
Tampa, FL, 33602
United States
Securities Counsel

Not Available
Investor Relations Firm
EVC Group
201 Mission Street
Suite 1930
San Francisco, CA, 94105
United States
Company History
  • Formerly=Cimarron Medical, Inc. until 9-2015
  • Formerly=Cimarron Software, Inc. until 6-2015
SNBP Security Details
Share Structure
Market Value1 $63,131,979 a/o Oct 17, 2017
Authorized Shares 100,000,000 a/o Oct 10, 2017
Outstanding Shares 36,704,639 a/o Oct 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 26,054,091 a/o Mar 31, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 179 a/o Mar 27, 2017
Short Selling Data
Short Interest 413 (-17.4%)
Sep 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security